NTDs: Overview - Unseen Scourges
- Diverse group of communicable diseases prevalent in tropical/subtropical climates.
- Affect >1 billion people globally, primarily in low-income populations.
- India bears a significant burden of many NTDs (e.g., Lymphatic Filariasis, Dengue).
- Lead to chronic disability, stigma, and poverty.
⭐ The WHO currently recognizes over 20 diseases/conditions as Neglected Tropical Diseases (NTDs).
Protozoal NTDs: Kala-azar's Curse
- Agent: Leishmania donovani. Vector: Sandfly (P. argentipes).
- Symptoms: Prolonged fever, splenomegaly (massive), hepatomegaly, weight loss, pancytopenia.
- PKDL: Post-Kala-azar Dermal Leishmaniasis; skin lesions after cure.
- Diagnosis: LD bodies (aspirate), rK39 test.
- Treatment: Liposomal Amphotericin B (LAmB), Miltefosine. (📌 LAmB First!)
⭐ Liposomal Amphotericin B is preferred for Kala-azar, especially in pregnancy and HIV co-infection.

Helminthic NTDs: Filarial & Wormy Woes
- Lymphatic Filariasis (LF)
- Agents: Wuchereria bancrofti (90%), Brugia malayi, B. timori. Vector: Mosquitoes.
- Features: Asymptomatic microfilaremia, adenolymphangitis (ADL), lymphedema, elephantiasis, hydrocele.
- Dx: Nocturnal blood smear (📌 Bancrofti by Night), ICT card (W. bancrofti antigen).
- Rx: Diethylcarbamazine (DEC) 6 mg/kg/day x 12 days.
-
⭐ India's strategy for Lymphatic Filariasis elimination involves annual Mass Drug Administration (MDA) with Diethylcarbamazine (DEC) and Albendazole.

-
%%{init: {'flowchart': {'htmlLabels': true}}}%% flowchart TD
Endemic["🌍 LF Endemic Area
• Lymphatic filariasis• High risk region"]
MDA["💊 MDA Strategy
• Mass Drug Admin• Population focus"]
Meds["💊 Drug Regimen
• DEC treatment• Albendazole dose"]
Interrupt["🛑 Interrupt Path
• Stop transmission• Break cycle"]
Eliminate["✅ Elimination Goal
• Disease free status• Public health win"]
Endemic --> MDA MDA -->|Annually| Meds Meds --> Interrupt Interrupt --> Eliminate
style Endemic fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style MDA fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534 style Meds fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534 style Interrupt fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style Eliminate fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252
* **Soil-Transmitted Helminthiases (STH)**
* Agents: *Ascaris lumbricoides* (roundworm), *Trichuris trichiura* (whipworm), Hookworms (*Ancylostoma*, *Necator*).
* Features: Malnutrition, anemia (hookworm), abdominal pain.
* Rx: Albendazole **400 mg** (single), Mebendazole **500 mg** (single) or **100 mg** BD x **3 days**.
* Prevention: National Deworming Day (Feb 10, Aug 10), WASH (Water, Sanitation, Hygiene).
## Key NTDs: Leprosy & Rabies Rampage
**Leprosy (Hansen's Disease):**
* Agent: *Mycobacterium leprae*.
* Cardinal Signs: Anesthetic skin patches (hypopigmented/erythematous), thickened peripheral nerves, positive slit-skin smear for AFB.
* Multi-Drug Therapy (MDT):
- Paucibacillary (PB) (≤5 lesions, smear -ve): Rifampicin + Dapsone for **6 months**.
- Multibacillary (MB) (>5 lesions, smear +ve): Rifampicin + Dapsone + Clofazimine for **12 months**.
* Lepra Reactions: Type 1 (Reversal), Type 2 (Erythema Nodosum Leprosum - ENL).
> ⭐ The duration of Multi-Drug Therapy (MDT) for Paucibacillary (PB) leprosy is **6 months**.
**Rabies:**
* Fatal viral zoonotic encephalitis, primarily via dog bites.
* Key Symptoms: Hydrophobia, aerophobia, paresthesia at bite site. Universally fatal once clinical signs appear.
* Post-Exposure Prophylaxis (PEP) is life-saving.

```mermaid
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD
Start["<b>🐕 Animal Bite</b><br><span style='display:block; text-align:left; color:#555'>• Exposure assessment</span><span style='display:block; text-align:left; color:#555'>• Risk evaluation</span>"]
WHO["<b>📋 WHO Category?</b><br><span style='display:block; text-align:left; color:#555'>• Classify severity</span><span style='display:block; text-align:left; color:#555'>• Determine PEP</span>"]
Cat1["<b>🩹 Category I</b><br><span style='display:block; text-align:left; color:#555'>• Licks on intact skin</span><span style='display:block; text-align:left; color:#555'>• No broken barrier</span>"]
Cat2["<b>🩹 Category II</b><br><span style='display:block; text-align:left; color:#555'>• Minor scratches</span><span style='display:block; text-align:left; color:#555'>• No bleeding seen</span>"]
Cat3["<b>🚨 Category III</b><br><span style='display:block; text-align:left; color:#555'>• Transdermal bites</span><span style='display:block; text-align:left; color:#555'>• Mucosa contact</span>"]
NoPEP["<b>✅ No PEP</b><br><span style='display:block; text-align:left; color:#555'>• No vaccine needed</span><span style='display:block; text-align:left; color:#555'>• Standard hygiene</span>"]
Treat2["<b>💊 Vaccine Only</b><br><span style='display:block; text-align:left; color:#555'>• Wound washing</span><span style='display:block; text-align:left; color:#555'>• Give ARV vaccine</span>"]
Treat3["<b>⚠️ Full PEP</b><br><span style='display:block; text-align:left; color:#555'>• RIG and ARV given</span><span style='display:block; text-align:left; color:#555'>• Immediate washing</span>"]
Start --> WHO
WHO --> Cat1 --> NoPEP
WHO --> Cat2 --> Treat2
WHO --> Cat3 --> Treat3
style Start fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style WHO fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style Cat1 fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8
style Cat2 fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8
style Cat3 fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C
style NoPEP fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252
style Treat2 fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534
style Treat3 fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C
NTD Control: India's Initiatives
- National Vector Borne Disease Control Programme (NVBDCP): Covers Lymphatic Filariasis (LF), Kala-azar (VL).
- National Leprosy Eradication Programme (NLEP): Leprosy elimination.
- Soil-Transmitted Helminthiases (STH) Control:
⭐ National Deworming Day in India, observed biannually, administers Albendazole to children aged 1-19 years for STH control.
- Albendazole dose: 400mg (2-19 yrs), 200mg (1-2 yrs).
- Accelerated Plan for Elimination of LF (APELF): 2018 onwards; Triple Drug Therapy (IDA).
- Kala-azar Elimination Programme: Target: <1 case/10k pop/block_level_target_for_VL_elimination_in_India_is_less_than_1_case_per_10000_population_at_the_block_level
High‑Yield Points - ⚡ Biggest Takeaways
- Lymphatic Filariasis: W. bancrofti, Culex mosquito, night smear, DEC; MDA for control.
- Kala-azar: L. donovani, sandfly, fever, splenomegaly, rK39 test, Amphotericin B.
- Leprosy: M. leprae, nerve damage, skin patches, MDT (Rifampicin, Dapsone, Clofazimine).
- Soil-Transmitted Helminths: Cause anemia, malnutrition; Albendazole for mass deworming.
- Rabies: Fatal viral NTD; Post-Exposure Prophylaxis (PEP) is crucial and life-saving.
- Trachoma: C. trachomatis, causes preventable blindness; SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental).